Abstract: A hose-attaching apparatus for leak-testing a pressurized hose may include a hose-attaching member. A bore may extend through the hose-attaching member. An internal annular cavity may extend coaxially around the bore. At least one of a detector probe hole and a detector probe may be connected to the internal annular cavity. At least a portion of the bore may have a diameter which is at least one of substantially equal to and less than a diameter of a hose to be leak-tested.

Abstract: An oral creatine formulation includes soluble creatine and polyethylene glycol, coated with an enteric coating. The most preferred soluble creatine is creatine HCl. The most preferred polyethylene glycols have an average molecular weight of from 3150 to 3685, although for particular formulation formulations and particular uses, the average molecular weight polyethylene glycols may range from 190 to 9000.

Abstract: An oral creatine formulation includes soluble creatine and polyethylene glycol, coated with an enteric coating. The most preferred soluble creatine is creatine HCl. The most preferred polyethylene glycols have an average molecular weight of from 3150 to 3685, although for particular formulation formulations and particular uses, the average molecular weight polyethylene glycols may range from 190 to 9000.

Abstract: A network for obfuscating satellite terminal transmission activity may include a satellite, a plurality of distributed satellite terminals transmitting signals to and receiving signals from the satellite, and a computer. The computer may compute how much transmission power spectral density each of the distributed satellite terminals is or would be transmitting based on allocated data rates of each of the distributed satellite terminals. The computer may calculate an aggregate transmission power spectral density which is being used or would be used by all of the distributed satellite terminals. The computer may calculate how much unused transmission power spectral density is available to the network for obfuscation by subtracting from a total network regulatory transmission power spectral density limit the aggregate transmission power spectral density.

Abstract: An oral creatine formulation includes soluble creatine and polyethylene glycol, coated with an enteric coating. The most preferred soluble creatine is creatine HCl. The most preferred polyethylene glycols have an average molecular weight of from 3150 to 3685, although for particular formulation formulations and particular uses, the average molecular weight polyethylene glycols may range from 190 to 9000.

Abstract: In a system for providing data content to and from a plurality of mobile platforms where each of the mobile platforms transmits a return link having an EIRP to a predetermined location via a satellite-mounted transponder, a method for controlling an EIRP of the aggregate return link emissions of the mobile platforms. The method includes the steps of determining a probability distribution of the EIRP of the return link for each of the mobile platforms; and determining a probability distribution of the EIRP for the aggregate return link emissions using the probability distributions of the EIRP of the return link for each of the mobile platforms; determining an aggregate off-axis EIRP density envelope for a predetermined probability level and the probability distribution of the EIRP for the aggregate return link emissions.

Abstract: The present invention provides a compound of formula I which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.

Abstract: The present invention provides a compound of formula I 1

Abstract: The present invention provides a compound of formula I 1

Abstract: In a system for providing data content to and from a plurality of mobile platforms where each of the mobile platforms transmits a return link having an EIRP to a predetermined location via a satellite-mounted transponder, a method for controlling an EIRP of the aggregate return link emissions of the mobile platforms. The method includes the steps of determining a probability distribution of the EIRP of the return link for each of the mobile platforms; and determining a probability distribution of the EIRP for the aggregate return link emissions using the probability distributions of the EIRP of the return link for each of the mobile platforms; determining an aggregate off-axis EIRP density envelope for a predetermined probability level and the probability distribution of the EIRP for the aggregate return link emissions.

Abstract: The present invention provides a compound of formula I 1

Abstract: The pyrimido?4,5-b!indoles (I) ##STR1## and lactams (XIII) of the invention are useful as pharmaceutical agents for a number of different indications.

Abstract: Substituted indoles of formula (I) ##STR1## are useful anti-AIDS pharmaceuticals.

Abstract: The present invention includes diaromatic substituted heterocyclic compounds (III) ##STR1## which are useful in treating individuals infected with the HIV virus.

Abstract: Disclosed are amino substituted steroids (XI) which contain an imidazolylpiperazinyl group attached to the terminal carbon atom of the C.sub.17 -side chain which are useful as pharmaceutical agents for treating a number of conditions.

Abstract: The present invention includes diaromatic substituted heterocyclic compounds (III) ##STR1## which are useful in treating individuals infected with the HIV virus. The invention includes certain previously generically disclosed anti-AIDS piperazinyl compounds (V) and a method of treating HIV infected individuals with the indoles of formula (V) and the anti-AIDS amines (X).

Abstract: Disclosed are amino substituted steroids (XI) which contain a pyridinylpiperazinyl group group attached to the terminal carbon atom of the C.sub.17 -side chain of the steroid which are useful as pharmaceutical agents for treating a number of conditions.

Abstract: Disclosed are amino substituted steroids (XI) which contain 4-[1,3,5-triazin-2-yl]- or 4-[1,2,4-triazin-3-yl]- 1-piperazinyl group attached to the terminal carbon atom of the C.sub.17 -side chain which are useful as pharmaceutical agents for treating a number of conditions.

Abstract: Disclosed are .DELTA..sup.9(11) -steroids (VI) and amino substituted steroids (XI) which contain an amino group attached to the terminal carbon atom of the C.sub.17 -side chain, more particularly amino steroids (Ia and Ib), aromatic steroids (II), .DELTA..sup.16 -steroids (IIIa and IIIb), reduced A-ring steroids (IV), .DELTA..sup.17(20) -steroids (Va and Vb) and .DELTA..sup.9(11) -steroids (VI) which are useful as pharmaceutical agents for treating a number of conditions.

Abstract: The claimed invention is to triazin-2-yl and triazin-3-yl piperazines which are useful intermediates in the preparation of amino substituted steroid (XI) which are useful pharmaceutical agents.